InMed amends merger deal with Mentari, files S-4 with SEC

July 7, 2026 4:23 AM

InMed Pharmaceuticals (NASDAQ: INM) announced an amendment to its previously disclosed all-stock merger agreement with privately held Mentari Therapeutics, a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found